Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer.
Saved in:
| Title: | Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer. |
|---|---|
| Authors: | Burris, Howard A.1 (AUTHOR) Howard.Burris@SarahCannon.com, Chan, Arlene2 (AUTHOR), Bardia, Aditya3 (AUTHOR), Thaddeus Beck, J.4 (AUTHOR), Sohn, Joohyuk5 (AUTHOR), Neven, Patrick6 (AUTHOR), Tripathy, Debu7 (AUTHOR), Im, Seock-Ah8 (AUTHOR), Chia, Stephen9 (AUTHOR), Esteva, Francisco J.10 (AUTHOR), Hart, Lowell11 (AUTHOR), Zarate, Juan Pablo12 (AUTHOR), Ridolfi, Antonia13 (AUTHOR), Lorenc, Karen Rodriguez12 (AUTHOR), Yardley, Denise A.1 (AUTHOR) |
| Source: | British Journal of Cancer. Aug2021, Vol. 125 Issue 5, p679-686. 8p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/s41416-021-01415-9 |
